Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease

被引：75

作者：

Lang, AE ^{[1
]}

Obeso, JA

机构：

[1] Univ Toronto, Toronto Western Hosp, Movement Disorders Clin, Toronto, ON M5T 2S8, Canada

[2] Univ Navarra, Clin Univ & Med Sch, Dept Neurol Neurosci, E-31080 Pamplona, Spain

来源：

ANNALS OF NEUROLOGY | 2004年 / 55卷 / 06期

关键词：

D O I：

10.1002/ana.20102

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：761 / 765

页数：5

共 47 条

[31] Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease [J].

Nakamura, T ;

Dhawan, V ;

Chaly, T ;

Fukuda, M ;

Ma, YL ;

Breeze, R ;

Greene, P ;

Fahn, S ;

Freed, C ;

Eidelberg, D .

ANNALS OF NEUROLOGY, 2001, 50 (02) :181-187

[32] THE ROLE OF PULSATILE VERSUS CONTINUOUS DOPAMINE-RECEPTOR STIMULATION FOR FUNCTIONAL RECOVERY IN PARKINSONS-DISEASE [J].

OBESO, JA ;

GRANDAS, F ;

HERRERO, MT ;

HOROWSKI, R .

EUROPEAN JOURNAL OF NEUROSCIENCE, 1994, 6 (06) :889-897

[33] Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. [J].

Obeso, JA ;

Guridi, J ;

Rodriguez-Oroz, MC ;

Agid, Y ;

Bejjani, P ;

Bonnet, AM ;

Lang, AE ;

Lozano, AM ;

Kumar, R ;

Benabid, A ;

Pollack, P ;

Krack, P ;

Rehncrona, S ;

Ekberg, R ;

Grabowski, M ;

Albanese, A ;

Scerrati, M ;

Moro, E ;

Koller, W ;

Wilkinson, SB ;

Pahwa, R ;

Volkmann, J ;

Allert, N ;

Freund, HJ ;

Kulisevsky, J ;

Gironell, A ;

Molet, J ;

Tronnier, V ;

Fogel, W ;

Krause, M ;

Funk, T ;

Kern, C ;

Kestenbach, U ;

Iansek, R ;

Rosenfeld, J ;

Churchyard, A ;

O'Sullivan, D ;

Pell, M ;

Markus, R ;

Bayes, A ;

Blesa, R ;

Oliver, B ;

Olanow, CW ;

Germano, IM ;

Brin, M ;

Jankovic, J ;

Grossman, RG ;

Ondo, WG ;

Vitek, JL ;

Bakay, RAE .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :956-963

[34] Preoperative response to levodopa is the best predictor of transplant outcome - Reply [J].

Olanow, CW ;

Freeman, TB ;

Kordower, JH .

ANNALS OF NEUROLOGY, 2004, 55 (06) :896-897

[35] A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease [J].

Olanow, CW ;

Goetz, CG ;

Kordower, JH ;

Stoessl, AJ ;

Sossi, V ;

Brin, MF ;

Shannon, KM ;

Nauert, GM ;

Perl, DP ;

Godbold, J ;

Freeman, TB .

ANNALS OF NEUROLOGY, 2003, 54 (03) :403-414

[36]

Parkinson Study Group, 2000, JAMA, V284, P1931

[37] A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa [J].

Rascol, O ;

Brooks, DJ ;

Korczyn, AD ;

De Deyn, PP ;

Clarke, CE ;

Lang, AE .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1484-1491

[38] Cabergoline in the treatment of early Parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa [J].

Rinne, UK ;

Bracco, F ;

Chouza, C ;

Dupont, E ;

Gershanik, O ;

Masso, JFM ;

Montastruc, JL ;

Marsden, CD ;

Dubini, A ;

Orlando, N ;

Grimaldi, R ;

Bergamasco, B ;

Mamoli, A ;

Scarpa, M ;

Scarano, M ;

Canal, N ;

Franceschi, M ;

Albanese, A ;

Bentivoglio, AR ;

Barone, P ;

Cicarelli, G ;

Malesani, R ;

Micheli, F ;

Muchnik, S ;

Pliego, L ;

Somoza, M ;

Gori, HE ;

Dominguez, R ;

Famulari, A ;

Aljanati, R ;

Mikkelsen, B ;

Olive, JM ;

Burguera, J ;

Miquel, F ;

GimenezRoldan, S ;

Mateo, D ;

Allain, H ;

Verin, M ;

Degos, JD ;

Destee, A ;

Warter, JM ;

Bernardi, F ;

Chillotti, C ;

Serra, JP ;

Garriga, MC ;

Benecke, R ;

Pirotta, RMN ;

Grossoni, M .

NEUROLOGY, 1997, 48 (02) :363-368

[39] Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection [J].

Rodriguez, MC ;

Obeso, JA ;

Olanow, CW .

ANNALS OF NEUROLOGY, 1998, 44 (03) :S175-S188

[40]

RODRIGUEZOROZ MC, IN PRESS J NEUROL NE

← 1 2 3 4 5 →